Xeris Pharmaceuticals (XERS)
(Delayed Data from NSDQ)
$2.96 USD
+0.06 (2.07%)
Updated Sep 19, 2024 03:59 PM ET
After-Market: $2.96 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.09 |
EPS Last Quarter | -0.10 |
Last EPS Surprise | 9.09% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.40 |
Next Year | -0.25 |
EPS (TTM) | -0.43 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 51.64M | 52.86M | 193.20M | 224.73M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 52.90M | 54.80M | 194.80M | 238.90M |
Low Estimate | 50.82M | 51.52M | 191.40M | 200.10M |
Year ago Sales | 48.32M | 44.39M | 163.91M | 193.20M |
Year over Year Growth Est. | 6.87% | 19.09% | 17.87% | 16.32% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.09 | -0.08 | -0.40 | -0.25 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.10 | -0.09 | -0.42 | -0.23 |
High Estimate | -0.06 | -0.06 | -0.35 | -0.09 |
Low Estimate | -0.10 | -0.10 | -0.43 | -0.40 |
Year ago EPS | -0.09 | -0.10 | -0.45 | -0.40 |
Year over Year Growth Est. | 0.00% | 20.00% | 11.11% | 37.50% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 3 | 2 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.09 | -0.08 | -0.40 | -0.25 |
7 Days Ago | -0.09 | -0.08 | -0.40 | -0.25 |
30 Days Ago | -0.09 | -0.08 | -0.40 | -0.25 |
60 Days Ago | -0.09 | -0.07 | -0.39 | -0.20 |
90 Days Ago | -0.09 | -0.07 | -0.41 | -0.20 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.09 | -0.08 | -0.40 | -0.25 |
Zacks Consensus Estimate | -0.09 | -0.08 | -0.40 | -0.25 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.10 | -0.14 | -0.10 | -0.09 | NA |
Estimate | -0.11 | -0.12 | -0.09 | -0.12 | NA |
Difference | 0.01 | -0.02 | -0.01 | 0.03 | 0.00 |
Surprise | 9.09% | -16.67% | -11.11% | 25.00% | 1.58% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more